Teladoc Health, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.86 | -100% | -50.65 | -100% |
| P/S |
|
1.36 | 4.06 | -66.54% |
|
|
| P/BV |
|
1.52 | 9.39 | -83.8% |
|
|
| P/FCF |
|
19.67 | 46.82 | -57.98% |
|
|
| Ev/Ebitda |
|
20.86 | 17.55 | 18.88% |
|
|
| Ev/S |
|
1.54 | 4.36 | -64.65% |
|
|
| Ev/FCF |
|
20.69 | 54.43 | -61.99% |
|
|
| E/P |
|
-0.0578 | 0.2163 | -126.72% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
2/10
|
7.38 | 20.15 | -63.37% | -118.14 | -106.25% |
| ROE |
|
-9.47 | -80.86 | -88.28% |
|
|
| ROA |
|
-5.02 | 6.71 | -174.72% |
|
|
| ROIC |
|
-48.92 | 15.68 | -412.06% |
|
|
| ROS |
|
-8.47 | 10.56 | -180.25% |
|
|
| ROCE |
|
-6.85 | 18.05 | -137.93% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
8.07 | 2.82 | 186.52% | 2.25 | +258.9% |
| Nеt Debt/Ebitda |
|
2.44 | 3.64 | -32.91% |
|
|
| Debt/Ratio |
|
0.3528 | 0.261 | 35.16% |
|
|
| Debt/Equity |
|
52.35 | 2.68 | 1854.41% |
|
|
| Debt/Net Income |
|
-7.03 | 6.35 | -210.76% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.29 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.33 | -100% | ||
| DSI |
|
0 | 0.7297 | -100% |
|
|
| Average dividend growth |
|
0 | -3.49 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.29 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.61 | -100% |
|
|
| Difference from average difference in sector |
|
-1.29 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
370.34 | 362.86 | 2.06% | ||
| Growth impulse Ebitda in 5 years |
|
-632.86 | 373.75 | -269.33% | ||
| Growth impulse Net Income in 5 years |
|
122.82 | 454.84 | -73% | ||
| Growth impulse FCF in 5 years |
|
919.33 | 306.17 | 200.27% | ||
| Growth impulse EPS in 5 years |
|
-2.97 | 455.99 | -100.65% |
IP Score
3.43/10
